Linzhao Cheng

Title: Linzhao Cheng: Innovator in Hematopoietic Stem Cell Research

Introduction

Linzhao Cheng is a prominent inventor based in Columbia, MD (US). He has made significant contributions to the field of immunology through his innovative research and patents. His work focuses on the modulation of systemic immune responses, particularly through the use of hematopoietic stem cells.

Latest Patents

Linzhao Cheng holds a patent titled "Modulation of systemic immune responses by transplantation of hematopoietic stem cells transduced with genes encoding antigens and antigen presenting cell regulatory molecules." This invention provides methods and compositions for modulating immune responses by utilizing hematopoietic stem cells that have been genetically modified. The invention includes bi-cistronic lentiviral expression vectors designed for antigen expression in antigen presenting cells. These vectors are intended for use in DNA vaccines targeting pathogens and tumor antigens, as well as for treating autoimmune diseases and establishing antigen tolerance. He has 1 patent to his name.

Career Highlights

Linzhao Cheng is affiliated with The Johns Hopkins University, where he continues to advance his research in immunology and stem cell therapy. His work has garnered attention for its potential applications in treating various diseases and enhancing immune responses.

Collaborations

Linzhao Cheng has collaborated with notable colleagues, including Drew M Pardoll and Yan Cui. These collaborations have further enriched his research and contributed to the advancement of knowledge in the field.

Conclusion

Linzhao Cheng is a key figure in the realm of hematopoietic stem cell research, with a focus on immune modulation. His innovative patent and ongoing work at The Johns Hopkins University highlight his commitment to advancing medical science. His contributions are paving the way for new therapeutic approaches in immunology.